BioCentury
ARTICLE | Clinical News

EchoGen Emulsion: Began a Phase III trial

January 2, 1996 8:00 AM UTC

Blinded readers will evaluate the ability of EchoGen to opacify (fill) the left ventricle and improve delineation of the endocardial border in patients with sub-optimal echocardiograms who are undergo...